SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005201-18-000027
Filing Date
2018-12-17
Accepted
2018-12-17 10:53:12
Documents
2
Period of Report
2018-12-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_154506197647847.html 4  
1 FORM 4 wf-form4_154506197647847.xml 4 3814
2 MCKEE POA ex-24.htm EX-24 3127
  Complete submission text file 0001005201-18-000027.txt   8300
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Issuer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
MCKEE WILLIAM (Reporting) CIK: 0001237262 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13111 | Film No.: 181237311